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Summary 
Background  
HIV testing is the critical entry point for HIV care and prevention service, but uptake of HIV 
testing and thus coverage of antiretroviral therapy, are much lower in older children and 
adolescents than in adults. We conducted a household randomised controlled trial to investigate 
the effect of economic incentives provided to caregivers of children aged 8-17 years on uptake 
of HIV testing and counselling (HTC) in Zimbabwe.  
Methods 
This randomised controlled trial was nested within a household HIV prevalence survey 
conducted among children aged 8-17 years in Harare. Households with one or more survey 
participants whose HIV status was not known were eligible to participate in the trial. Eligible 
households were randomised to i) no incentive ii) a fixed US$2 incentive or iii) participation in 
a lottery, if the participant presented for HTC. Odds ratios were estimated using logistic 
regression comparing HIV test uptake in the incentivised with the non-incentivised arm 
adjusted for community and number of children as fixed effect and research assistant as random 
effect. Primary outcome was proportion of households with at least one child undergoing HIV 
testing within four weeks of enrolment. The trial was registered (PACTR201605001615280). 
Findings 
Of 2050 eligible households recruited between 4.08.2015 and 18.12.2015, 649 (32%), 740 
(34%) and 661 (32%) were randomised to no incentive, a fixed US$2 incentive and a lottery. Of 
these households, 19.7% (93/472), 48.3% (316/654) and 39.7% (223/562) respectively had at 
least one child tested. Adjusted odds ratios for HIV testing were 3.67 (95%CI 2.77-4.85, 
p<0.001) for the US$2 and 2.66 (95%CI 2.00-3.55, p<0.001) for the lottery incentives 
compared to no incentive. 
Interpretation 
3 
Fixed and lottery-based incentives increased the uptake of HIV testing among older children 
and adolescents, a key hard-to-reach population. This strategy would be sustainable in the 
context of vertical HIV infection as repeated testing would not be required. 
Funding: Wellcome Trust 
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Introduction 
Antiretroviral therapy (ART) effectively prevents progression to AIDS and mortality among 
those living with HIV and decreases the likelihood of onward transmission. The number of 
HIV-related deaths among adolescents, however, has more than tripled over the last decade. 
Adolescents are the only age-group in which HIV-associated mortality is rising, despite the 
global scale-up of ART programmes.1 Delayed diagnosis of young people living with HIV is 
increases the risk of immunosuppression resulting in increased mortality.2 In addition, initiation 
of ART at advanced stages of disease is associated with much poorer outcomes.3,4 The 
prevalence of undiagnosed HIV is particularly high among older children and adolescents.5,6 A 
recent meta-analysis from South Africa estimated that only 14% of 15-24 years olds living with 
HIV were accessing ART.7 
 
HIV testing is the essential entry point for both treatment and prevention efforts. Conventional 
HIV testing strategies such as facility-based provider-initiated HIV testing and counselling 
(PITC), recommended by the World Health Organization since 2007 in high HIV prevalence 
settings, have not been sufficient to reduce the burden of undiagnosed HIV in this age-group.8 
Community-based strategies such as mobile testing units and door-to-door testing and one-stop 
campaigns have been effective in adults, but tend to either exclude adolescents or be less 
effective in increasing uptake of HIV testing in this age-group.9,10 This might partly be due to 
issues of consent to HIV testing. Novel approaches are therefore required to improve coverage 
of HIV diagnosis and treatment in this age-group.  
 
Incentivisation is a strategy that has been used with varying success in health programmes to 
influence behaviours including smoking, illicit substance use and poor diet, as well as for 
achieving specific targets such as completion of vaccination.11,12 The principle underlying use 
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of incentives is the psychological theory of contingency management, whereby stimulus control 
and positive reinforcement are used to change behaviour.13 Conditional and unconditional 
incentives have been shown to reduce pregnancy rates and sexual risk behavior for HIV 
acquisition among adolescents and young adults in Kenya, Malawi and South Africa.14-17 
Economic incentives have also been applied to encourage testing for sexually transmitted 
infections including HIV.18 The provision of financial incentives increased uptake of HIV 
testing among adults in Malawi19 and unemployed men in South Africa.20  
 
In sub-Saharan Africa, where 90% of the world’s children with HIV live, testing of minors 
requires consent from guardians with the exception of emancipated minors. The age of ability to 
give independent consent varies across countries, but in the majority of sub-Saharan African 
countries it is 18 years.21 Therefore, for minors to access testing requires the willingness and 
engagement of guardians. The aim of this study was to evaluate the impact of financial 
incentives provided to guardians on uptake of HIV testing and counseling in older children and 
adolescents aged 8-17 years in Harare, Zimbabwe.  
 
Methods 
Study design  
We conducted a three-arm household-randomised controlled trial comparing provision of no 
incentives (control arm) with either a fixed incentive of US$2 or participation in a lottery 
(intervention arms) and the impact on HIV test uptake at primary health care clinics (PHC) by 
children aged 8-17 years. The trial was conducted and analysed according to the CONSORT 
guidelines. 
 
Setting and participants 
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The trial was nested within a household survey to estimate the prevalence of undiagnosed HIV 
among children aged 8-17 years in seven communities in Harare. As part of the prevalence 
survey participants were anonymously tested for HIV by providing oral fluid samples. 
Participants and caregivers did not receive these results. Each community is served by PHC 
providing acute and antenatal care services. The survey took place between January and 
December 2015 and the trial was from August to December 2015.  
 
Results of the prevalence survey have been reported elsewhere.22 In brief, a sample of census 
enumeration areas (CEAs), defined as the smallest delimited census area in the study 
communities, was selected from the 2012 National Census sampling frame using simple 
random sampling. All households in the selected CEAs were enumerated, and any household 
with one or more residents aged 8-17 years old was eligible to participate in the prevalence 
survey. Households were eligible for the trial if they included at least one prevalence survey 
participant whose HIV status was not known. 
 
Randomisation and masking 
Following enumeration, eligible households were randomized to one of three trial arms, namely 
i) no incentive ii) receipt of US$2 or iii) participation in a lottery to win a cash prize if a survey 
participant in the household presented to the PHC in the study community for HIV testing. US$ 
is the official currency in Zimbabwe since 2009. The growth domestic product in Zimbabwe 
was US$1008.6 per capita.23 US$2 would pay for a return journey for two individuals from the 
outskirts of Harare to the city centre. Random allocation was built into the tablet used for data 
collection. Those randomised to the lottery had a 1 in 8 chance of winning US$5 or US$10. 
There was no separate price draw for US$5 and US$10, both prices were drawn from the same 
box at the clinics.  Randomisation was done at household level as it was not feasible to allocate 
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participants in one household to different trial arms. An independent statistician performed the 
random allocation of households using STATA v14.0. Randomisation was based on the list of 
households that were enumerated prior to the prevalence survey. This included households that 
were subsequently not eligible because they did not have a child in the target age group. 
However, the reasons for randomizing the enumerated households rather than the households 
eligible for the survey was to prevent fieldworkers from influencing random allocation. If more 
than one survey participant from a household randomised to the intervention arms attended for 
testing, each would be given the incentive. 
 
As the trial was embedded in the prevalence survey, the survey fieldworkers enrolled children 
into both the survey and the trial, and recruitment into the trial occurred on the same visit as that 
for enrolment into the prevalence survey. The survey fieldworkers were therefore not blinded.  
 
Procedures 
Written informed consent in the local language (Shona) was sought from the guardian and 
assent from the participants. Consent to participate in the trial was sought separately from 
consent to participate in the prevalence survey. Hence households with one or more survey 
participants could decline to participate in the trial. 
 
Fieldworkers visited eligible households and following informed consent collected data on 
household socio-demographic characteristics. If an eligible child was absent, two further visits 
were made within two weeks unless the household head reported the child was expected to be 
absent for more than two weeks (child coded as “unavailable”). For each participant, history of 
previous HIV testing, including the date and location of the test(s) and whether the participant 
was taking ART or cotrimoxazole prophylaxis was recorded using a questionnaire administered 
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to the participant’s guardian. Participants were asked to provide documentary evidence of 
previous HIV testing, and all participants underwent anonymised HIV testing.22 All households 
participating in the prevalence survey were provided with written information about benefits of 
HIV testing. 
 
Households with at least one survey participant with i) no documented evidence of a positive 
HIV test or ii) a negative HIV test result within the past six months were invited to participate 
in the trial. Trial participants were given vouchers stating their survey study number and the 
trial arm to which their household had been randomised. Free HIV testing at PHCs was 
available for all participants and other members of the household at any time but incentives 
were only provided for those with a trial voucher. A research assistant was available at the 
clinics to conduct HIV testing and counselling. HIV testing was carried out according to 
national guidelines, and those who tested HIV-positive were referred for HIV care at the same 
clinic. As per national guidelines HIV testing required both guardian consent and child assent. 
Staff at the clinics and the research assistant had undergone repeated training to provide age-
appropriate information, testing and counselling to prevent coercion. A research assistant based 
at the clinics reported any adverse events and ensured appropriate follow-up and linkage to care 
for any child diagnosed with HIV.  
 
Ethical approval was obtained from the Medical Research Council of Zimbabwe, the London 
School of Hygiene and Tropical Medicine Ethics Committee and the Institutional Review Board 
of the Biomedical Research and Training Institute, Harare, Zimbabwe.   
 
Outcome  
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The primary outcome was proportion of households that underwent HIV testing within four 
weeks of enrolment. A household was categorised as having tested for HIV if at least one child 
in the participating household presented for HIV testing at the PHC. An intention to treat 
analysis was performed. 
 
Statistical analysis  
The unit of randomisation and analysis was the household. Participants and field workers were 
not blinded to intervention or control arm. The statistician was blinded to trial arm for analysis 
of the trial outcomes. 
 
Assuming 20% of households in the control arm sent a child for testing at the clinic, 392 
participating households per arm would provide 90% power to detect a 50% increase in uptake 
of testing in an intervention arm versus the control arm. With a three arm trial this would 
require a total of 1176 households, and allowing for 25% refusal 1568 households would need 
to be surveyed.  
 
Data was collected by the fieldworker on Nexus 7 2013 tablets running Open Data Kit (ODK) 
software and transferred to STATA (Version 13.1) for data analysis. Descriptive statistics were 
conducted on the socio-demographic characteristics of the eligible households and the 
participants. For continuous and non-parametric variables, medians and inter-quartile ranges 
were calculated, and for categorical variables frequencies and percentages were 
estimated.  Odds ratios were estimated using logistic regression to compare household HIV 
testing uptake (i.e. at least one child testing for HIV) in the arms receiving the two different 
intervention strategies with the non-incentivised arm, adjusting for community and number of 
children in the household as fixed effects and research assistant as a random effect. Adjustment 
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for community and research assistant were made a priori. Adjustment for number of children 
was performed to account for imbalance in different arms. Logistic regression was chosen as the 
method for analysis to account for the effect of clustering within communities and by research 
assistant. Research assistant was included as a random effect to allow for the possibility that 
some research assistants were better at explaining the study or convincing caregivers to take 
children for testing. 
 
A sensitivity analysis was performed investigating individual HIV test uptake by arm adjusting 
for community and number of children in the household as fixed effects, with household and 
research assistant as a random effect. Odds ratios investigating factors predicting individual 
HIV test uptake were estimated using logistic regression among children randomised to the 
control arm, adjusted for household as a fixed effect and research assistant as a random effect. 
Children’s schooling was recoded into two categories based on the recommended grade for their 
age; those who were in the appropriate grade for their age, any higher grade, or one grade 
below, versus children more than one grade below their age or those who had never been to 
school. Reported general health was recoded into excellent/good and fair/poor. 
The trial is registered with the Pan African Clinical Trials Registry 
(PACTR201605001615280). 
 
Data sharing 
The prevalence survey dataset in which the trial was embedded is stored in the DataCompass 
secure online repository, curated by the London School of Hygiene & Tropical Medicine. The 
DOI ishttp://dx.doi.org/10.17037/DATA.174 https://doi.org/10.17037/DATA 
 
Role of the funding source 
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The funder had no role in the study design, data collection, data analysis, data interpretation, 
report writing, or decision to submit the report for publication. The corresponding author has 
full access to all data in the study and had final responsibility for the decision to submit the 
publication. 
 
Results 
A total of 2050 households were eligible to participate in the prevalence survey based on the 
enumeration of the randomly selected CEAs. Of these, 649 (32%), 740 (34%) and 661 (32%) 
were randomised to receiving no incentive, US$2 or participating in a lottery. Household 
enrolment took place between August and December 2015. The US$2 arm had more 
households than the intervention arms partly due to chance imbalance at randomization. In 
addition the control households were more likely to have an absent child at the time of the 
survey visit. These households were therefore not eligible to participate. Of the 2050 
households, 1703 participated in the prevalence survey. Of the 1703 households, 1688 were 
enrolled into the trial, 22 households having no undiagnosed child and 1 household refusing 
consent (Figure 1). Of the participating households 55% had one child, 29% two, 11% three, 
3% four and 1% more than four children.  
 
Household characteristics   
Socioeconomic characteristics were balanced over the three arms (Table 1). The majority of 
household heads had at least secondary education and almost half of the households owned their 
dwelling. Half of the households did not have a regular income or had a monthly income below 
US$100. Most guardians felt comfortable with the idea of an HIV-infected child visiting the 
household or for their child to share food and play with an HIV-infected child.  
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Impact of the intervention  
In the control arm, 19.7% of households (93/472) had at least one child tested for HIV 
compared with 48.3% (316/654) in the arm with US$2 incentive and 39.7% (223/562) in the 
lottery. When comparing each incentive to no incentive the adjusted odds ratios were 3.67 
(95%CI 2.77-4.85) for the US$2 and 2.66 (95%CI 2.00-3.55) for the lottery. The characteristics 
of individual trial participants by arm are shown in Appendix Table 1. The effect was more 
pronounced in the sensitivity analysis where individual children in the US$2 arm and the lottery 
arm were compared with children in the control arm. The adjusted odds ratios were 4.86 
(95%CI 3.84-6.17) and 3.23 (95%CI 2.53-4.13) respectively (Appendix Table 2). No adverse 
events were reported. 
 
Factors associated with HIV testing of participants in the control arm 
Factors associated with increased uptake of HIV testing in the control arm included lower 
household income, smaller household size and older age of the participants (Table 3).   
 
Discussion 
Uptake of HIV testing among children and adolescents in households that received a financial 
incentive was higher than among households that did not receive an incentive. A lottery with a 
1 in 8 probability of receiving an incentive had a similar effect to a fixed incentive of US$2.  
 
Uptake of HIV testing among households randomized to receiving no incentive was low (19%) 
despite HIV testing being free of charge. This may be because diagnostic HIV testing at the 
clinic was available only during working hours, and bringing children to the clinic for HIV 
testing require guardians having to take time off work or looking after other children and 
possibly children missing school.12,24 Diagnostic HIV testing was not performed during the 
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household visit as it may have affected participation in the prevalence survey, but dedicated 
research staff were available at the PHCs so that those attending for HIV testing did not have to 
wait in the routine clinic queue.  
 
The use of incentives to increase HIV testing is grounded in two economic concepts related to 
decision-making. Firstly, an economic incentive may mitigate against the “indirect” costs of 
HIV testing incurred by the client, such as loss of income through time taken off work and 
transport costs. These may be an even larger cost consideration for a child who is likely to be 
economically dependent. Secondly, some individuals may display what is termed “present-
biased” preferences of a behavior. They place disproportionate emphasis on the immediate costs 
and benefits, such as economic burden or fear of a positive result compared to future costs and 
benefits.13 Incentives may bring forward in time the “benefits” and sway the decision of the 
child, the guardian or both.   
 
Incentives have been used for the completion of goal-directed activities such as hepatitis B 
vaccination, tuberculosis screening, and testing for sexually transmitted infections.11,25 Several 
studies have shown improved uptake of HIV testing among young people and first-time testers 
in sub-Saharan Africa.19,20 However, incentivised HIV testing has never been investigated 
among children and adolescents. A recent study in Tanzania showed that incentivising universal 
HIV testing in adults with US$1.30-6.40 was highly cost-effective.26 The costs per quality-
adjusted life-year (QALY) gained was US$70 for prevalent and US$620 for incident HIV 
infections. However, HIV prevalence is generally lower in children and adolescents compared 
to adults and therefore cannot be generalised to this age group. This may be off-set partly by the 
fact that children and adolescents have more “unlived” life-years and are not at ongoing risk of 
being HIV-infected until they become sexually active and therefore HIV testing is a “one-off” 
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activity in childhood. This is particularly important as the sustainability of incentivisation 
strategies is of concern, particularly for enforcing long-term changes in health behaviours, for 
example adherence to ART.27,28  
 
In low-income settings, lotteries may be a more affordable strategy than fixed incentives. In our 
study, the proportion of participants who underwent HIV testing in the lottery arm almost 
tripled compared to the control arm, and the effect was similar to that of a fixed incentive. 
These findings are in contrast with studies investigating the effect of fixed financial incentives 
and/or lottery to enhance uptake of circumcision.29,30 Fixed incentives increased uptake of 
circumcision, but lotteries had no or a non-significant effect.29,30 Contextual factors need to be 
taken into account when designing an incentivisation strategy. Careful consideration is needed 
to determine the amount, type and frequency of incentives, as well as the probability of 
receiving an incentive.17 These factors influence both the likelihood of affecting the desired 
behavior as well as enabling autonomic decision making by the client. 
 
Ethicists have raised concerns regarding coercion and equity when using incentives to promote 
healthy behavior.31 In particular, when considering incentivisation of guardians for health-
related activities targeting their children, the potential of coercion of children from their 
caregivers should be considered. Lottery systems may be ethically less problematic because 
receipt of the incentive does not rely exclusively on displaying the desired behavior, but 
includes an element of chance. The national South African ‘Right to Know’ HIV testing 
campaign discussed using lottery incentive systems to encourage HIV testing in the general 
population.32  
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The strengths of the study include an incentivisation strategy directed at guardians who are the 
gatekeepers to minors accessing health care, clear denominators and a large sample size. We 
acknowledge several limitations. First, the trial was nested in a prevalence survey involving 
household visits. Whether the interaction between fieldworkers and households and the 
information provided during these visits had any effect on the uptake of testing is unknown. 
Second, the number of households randomized to each arm were relatively equally balanced, 
but the number of households eligible to participate were not, which may have introduced 
selection bias. However, adjustments were made for number of children per household to 
account for imbalance. Households randomized to not receiving an incentive were more likely 
to indicate that they did not have a child in the target age group and therefore were ineligible. 
These households might have “silently” refused to participate, but felt uncomfortable refusing 
openly. Thus the incentives might have increased the participation in the trial and uptake of 
testing. Household characteristics of the participating household were similar across the three 
groups except for the number of children in each household. This did not affect the effect 
estimate, as the outcome was measured on household level and adjusted for the number of 
children in a household. Third, children in the non-incentivised group may have tested without 
identifying themselves as trial participants resulting in differential outcome misclassification 
and possibly overestimation of the effect. Fourth, as previously discussed the effect of 
incentives is context-specific. While the broad principle may be generalisable to other settings, 
the size of the effect is less likely to be.  
 
The Joint UN Programme on HIV/AIDS (UNAIDS) has set ambitious 90-90-90 targets, 
whereby 90% of people living with HIV infection should be diagnosed, 90% of HIV-infected 
individuals should be on ART, and 90% of those on ART should be virologically suppressed by 
2020.33 If achieved, this would lead to a 90% reduction in AIDS-related mortality and HIV 
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incidence by 2030, and eliminate HIV as a public health threat. Reducing the burden of 
undiagnosed HIV is the critical first step to realising the UNAIDS targets. Existing strategies 
are clearly inadequate to address the substantial burden of undiagnosed HIV infection in 
adolescents, and novel approaches will be required if the targets are to be met in this age-group. 
Our study demonstrates that incentives targeted at caregivers substantially improves HIV 
testing rates among adolescents. Looking ahead, studies are needed to investigate the cost-
effectiveness of this approach and careful thought given to the social and cultural context if 
strategies such as this are to be brought to scale.     
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Research in context 
Evidence before the study 
Dramatic improvements in survival have been achieved since the advent of antiretroviral 
therapy (ART). The critical step to accessing HIV treatment is HIV testing and counselling 
(HTC). Older children and adolescents have particularly high rates of undiagnosed HIV and 
therefore much lower coverage of ART than adults. Existing HTC strategies either exclude or 
are insufficient to meet the needs of this age-group. Novel strategies will be required if we are 
to meet the ambitious UNAIDS 90-90-90 targets (which stipulate that 90% of HIV-infected 
individuals should be diagnosed) in this age-group. Incentivisation is a strategy that has been 
used in a variety of public health programmes to influence health-related behavior or to achieve 
specific targets. 
 
 
We identified two recent systematic reviews investigating the impact of incentives on uptake of 
HIV testing.18,27 Additionally we searched the Cochrane Review database, ClinicalTrials.gov, 
the WHO International Clinical Trial Registry, MEDLINE, Embase and Web of Science with 
the following terms: “HIV”, “incentives”, “voucher”, “lottery”, “conditional cash transfer” and 
“prize draw” for papers not included in the review. We identified two randomised controlled 
trials conducted in the USA34 and Malawi19 respectively, and two observational studies 
conducted among high risk groups, unemployed men20 and adolescents35, in South Africa. All 
the studies demonstrated higher uptake in the incentivised groups, but none used a lottery 
approach. The only randomised controlled trial investigating the effect of incentives in sub-
Saharan Africa was focused on adults and conducted in 2004 before ART became widely 
available.    
Added value of the study  
18 
Our study is the first randomised controlled trial using incentives to improve uptake of HIV 
testing among older children and adolescents in sub-Saharan Africa. Notably, using the 
household as the unit of randomisation acknowledges the central role of the family and guardian 
in making the decision about whether the child or adolescent is tested or not. We used two 
different incentivisation strategies, namely a fixed incentive of US$2 or a lottery with a 1:8 
chance to receive US$5 or 10.  While uptake of testing was higher among households 
randomised to fixed incentives, participation in the lottery increased uptake 3-fold. This may be 
a more cost-effective strategy in resource-constrained settings, and potentially less coercive as 
the client is aware that an incentive may not be forthcoming. The strategy has potential for 
scalability and sustainability for identifying those with perinatally acquired HIV, as there is no 
ongoing risk until sexual debut.    
Implications of the available evidence 
Financial incentives show promise for improving engagement in HIV testing especially among 
high risk groups. A better understanding of durability, scalability, ease of implementation, 
sustainability and cost-effectiveness of these different approaches is needed for maximising the 
impact of incentives in reaching the ambitious 90-90-90 targets.   
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Figure 1: Study profile 
 
 
Unavailable = child absent at initial household visits and absent at two further visits or household head reporting 
that the child was expected to be absent for more than two weeks 
*The households remained in the analysis as other children in the household participated 
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Table 1: Baseline characteristics of households by randomisation arm 
  No incentive 
N=472 
N (%) or median 
(IQR) 
US$2 
N=654 
N (%) or median 
(IQR) 
Lottery 
N=562 
N (%) or median 
(IQR) 
Median (IQR) household size 5 (4-6) 5 (4-6) 5 (4-6) 
Median (IQR) eligible children in household 1 (1-2) 2 (1-2) 2 (1-2) 
Median (IQR) Age of household head1 41(35-49) 42(36-51) 41(35-49) 
Education of HH head1  
None/primary 
Secondary 
Higher 
 
14 (3.0%) 
397 (84.3%) 
60 (12.7%) 
 
34 (5.2%) 
521 (79.7%) 
99 (15.1%) 
 
28 (5.0%) 
468 (83.3%) 
66 (11.7%) 
Ownership of dwelling1  
Own dwelling 
Rent 
Use dwelling without rent 
 
199 (42.3%) 
249 (52.9%) 
23 (4.9%) 
 
314 (48.0%) 
307 (46.9%) 
33 (5.1%) 
 
234 (41.6%) 
298 (53.0%) 
30 (5.3%) 
HH owns fridge1     
Yes 429 (91.1%) 614 (93.9%) 518 (92.2%) 
HH owns car or truck1    
Yes 71 (15.1%) 112 (17.1%) 85 (15.1%) 
HH owns television1    
Yes 460 (97.7%) 650 (99.4%) 549 (97.7%) 
HH members earning regular salary1 
0 
1 
>1 
 
188 (39.9%) 
249 (52.9%) 
34 (7.2%) 
 
265 (40.5%) 
322 (49.2%) 
67 (10.2%) 
 
255 (45.4%) 
257 (45.7%) 
50 (8.9%) 
Regular HH income per month1 
No regular income- <US$200 
US$200-500 
>US$500 
 
274 (58.2%) 
128 (27.2%) 
69 (14.7%) 
 
355 (54.3%) 
161 (24.6%) 
138 (21.1%) 
 
338 (60.1%) 
140 (24.9%) 
84 (15.0%) 
Guardian comfort with child playing with HIV+ child1    
Very comfortable 447 (94.9%) 627 (95.9%) 544 (96.8%) 
Guardian comfort with HIV+ child visiting HH1    
Very comfortable 442 (93.8%) 618 (94.5%) 529 (94.1%) 
Guardian comfort with child sharing food with HIV+ child1    
Very comfortable 430 (91.3%) 606 (92.9%) 523 (93.4%) 
Child aged 8-17 in the household diagnosed with HIV 6 (1.3%) 19 (2.9%) 12 (2.1%) 
Child aged 8-17 in the household living with HIV 8 (1.7%) 30 (4.6%) 24 (4.3%) 
HH=household, IQR=interquartile range 1 1 missing value 
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Table 2: Effect of provision of and type of incentives on uptake of testing at household level 
 
 At least 1 child 
went to clinic 
Crude OR  
(95% CI) 
p-value Adjusted OR*  
(95% CI) 
p-value 
No Incentive 
US$2 
Lottery 
93/472 (19.7%) 
316/654 (48.3%) 
223/562 (39.7%) 
1 
3.81 (2.90, 5.01) 
2.68 (2.02, 3.56) 
 
<0.0001 
<0.0001 
1 
3.67 (2.77, 4.85) 
2.66 (2.00, 3.55) 
 
<0.0001 
<0.0001 
*Adjusted for community and number of children in household, as fixed effects, and research assistant as a 
random effect 
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Table 3: Household and individual level factors associated with HIV testing in the 
control arm 
Variable 
Crude OR  
(95% CI)* 
p-value 
Adjusted OR  
(95% CI)* 
p-value 
Household level     
Does household own dwelling     
No 1    
Yes 0.85 (0.55, 1.230) 0.44   
Household income 
No regular salary - <US$ 200 
US$ 200 – US$ 500 
>US$ 500 
 
1 
0.61 (0.35, 1.06) 
0.43 (0.21, 0.91) 
 
 
0.080 
0.028 
 
1 
0.59 (0.34, 1.05) 
0.51 (0.24, 1.11) 
 
 
0.075 
0.089 
Number of children aged 8-17 
(reference category =1) 
0.62 (0.48, 0.79) <0.0001 0.61 (0.47, 0.79) <0.0001 
Age of household head (years) 
<30 
30-60 
>60 
 
1 
0.46 (0.16, 1.32) 
0.94 (0.44, 2.01) 
 
 
0.15 
0.88 
  
Individual level     
Gender     
Male 1    
Female 0.79 (0.52, 1.20) 0.26   
Age     
8-12 1  1  
13-17 1.38 (0.91, 2.09) 0.13 1.46 (0.94, 2.25) 0.090 
Orphan     
No 1    
Single or double orphan 1.46 (0.80, 2.64) 0.21   
General Health     
Good 1  1  
Fair/poor 1.94 (0.75, 5.05) 0.17 1.59 (0.54, 4.63) 0.41 
Ever admitted to hospital     
No 1    
Yes 0.76 (0.22, 2.65) 0.67   
Chronic skin conditions     
No 1  1  
26 
Variable 
Crude OR  
(95% CI)* 
p-value 
Adjusted OR  
(95% CI)* 
p-value 
Yes 1.94 (0.68, 5.50) 0.21 1.61 (0.51, 5.13) 0.42 
Schooling (for age)     
≤ 1 grade behind for age 1  1  
>1 grade behind for age  1.31 (0.83, 2.06) 0.24 1.21 (0.76, 1.95) 0.42 
Caregiver     
Biological parent 1    
Not biological parent 0.80 (0.47, 1.36) 0.40   
*Adjusted for household as a fixed effect and research assistant as a random effect 
